Pharma Journalist -

GSK plc announced that the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower respiratory tract…
Read More...

Forge Biologics announced a gene therapy development and manufacturing collaboration with Labcorp. As a result of this strategic collaboration, gene therapy clients across the…
Read More...

Kamada Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved its application to manufacture CYTOGAM (Cytomegalovirus Immune Globulin Intravenous ) (CMV-IGIV) at…
Read More...

Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, is pleased to announce that it has closed on an important land purchase in Wallonia, Belgium,…
Read More...

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) approved KALYDECO (ivacaftor) for use in children with cystic fibrosis (CF) ages 1 month to…
Read More...

Magenta Therapeutics, Inc. and Dianthus Therapeutics, Inc. announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction. The…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has granted approval for Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR)…
Read More...

BrightPath Biotherapeutics Co., Ltd., a clinical stage biotechnology company focused on the development of cell therapies derived from invariant natural killer T (iNKT) cells, and…
Read More...

Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has approved QALSODY (tofersen) 100 mg/15mL injection for the treatment of amyotrophic lateral sclerosis (ALS) in…
Read More...

Our health system exists to allow all people to fulfill their human potential. Now, the challenge of undoing a legacy of systemic disparities falls on a our shoulders as we continue to…
Read More...